United States Pharmacopeial Convention
Organization that sets standards for medicines, food ingredients, and dietary supplements.
Based in MD
🤖
AI Overview
With $1.5M in lobbying spend across 28 quarterly filings, United States Pharmacopeial Convention is a significant lobbying presence.
$1.5M
Total Lobbying Spend
28
Quarterly Filings
1
Lobbying Firms Used
7
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $290K |
| 2019 | $300K |
| 2020 | $150K |
| 2021 | $160K |
| 2022 | $130K |
| 2023 | $200K |
| 2024 | $210K |
| 2025 | $100K |
Lobbying Firms
AKIN GUMP STRAUSS HAUER & FELD
What They Lobby For
- FDA and NIH Workforce Authorities Modernization Act; FDA User Fee re authorization legislation; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; OTC monograph legislation; compounding; opioids.
- H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; OTC monograph legislation; compounding; opioids.
- OTC monograph legislation; compounding; opioids; dietary supplements; 2020 Agricultural FDA appropriations legislation.
- Compounding; 2020 Agricultural FDA appropriations legislation; Lower Health Care Costs Act (s.1895); Drug Pricing.
- Compounding; 2020 Agricultural FDA appropriations legislation; Lower Health Care Costs Act (s.1895); Drug Pricing; Cures 2.0.
- Compounding; Drug Pricing; Cures 2.0; Lower Health Care Costs Act; CARES Act; Additional COVID-19 relief legislation; HEROES Act; National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act; COVID-19 pandemic response
- Compounding; Drug Pricing; Cures 2.0; CARES Act (S. 3548/H.R. 748); Additional COVID-19 pandemic response legislation; HEROES Act (H.R. 6800); National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act (H.R. 4866); FY 2021 appropriations; Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.
- Compounding; Lower Health Care Costs Act (S.1895); Drug Pricing; 21st Century Cures Act 2.0; CARES Act (S. 3548/H.R. 748); COVID-19 pandemic response; HEROES Act (H.R. 6800); National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act (H.R. 4866); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; FY 2021 Consolidated Appropriations Act (H.R. 133)
- Compounding; Drug Pricing; 21st Century Cures Act 2.0; COVID-19 pandemic response; Supply chain reform; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations Act (H.R. 133).
- Compounding; Drug pricing; 21st Century Cures Act 2.0; COVID-19 pandemic response; Supply chain reform; American Rescue Plan Act (P.L. 117-2); FY 2022 Appropriations.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.